Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Everolimus in Treating Patients With Recurrent or Progressive Low-Grade Glioma

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by University of California, San Francisco
Sponsor:
Information provided by (Responsible Party):
Susan Chang, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00831324
First received: January 27, 2009
Last updated: May 27, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2017
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)